Clinicians should think twice before prescribing DPP-4 inhibitors for diabetes

Evid Based Med. 2016 Jun;21(3):81-2. doi: 10.1136/ebmed-2016-110436. Epub 2016 Apr 21.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors / pharmacology*
  • Humans
  • Hypoglycemic Agents / therapeutic use*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents